Cardiology

Uzm. Dr. Özlem Önder

Doctor and researcher Medipol Mega Üniversite Hastanesi İstanbul
Heart Failure
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source

CV

Education and experience

From source

Education

  • 2018İstanbul Üniversitesi Kardiyoloji Enstitüsü, Kardiyolojimedipol.com.tr
  • 2012Trakya Üniversitesi, Tıp Fakültesimedipol.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyCardiologymedipol.com.trFrom source
  • InstitutionMedipol Mega Üniversite Hastanesimedipol.com.trFrom source
  • Area of workHeart FailureExtracted from 2 publications · Model version —From source
  • Publications7 publicationsOpenAlexFrom source
  • Languagesİngilizcemedipol.com.trFrom source
  • ORCID0009-0004-5704-2145ORCIDFrom source
  • Last synchronised4 November 2026 20:29https://medipol.com.tr/doktorlarimiz/uzmdr-ozlem-ondermedipol.com.tr

Scientific work

Publications on Heart Failure

7 publications

  1. Ultrathin-strut drug-eluting stents are associated with lower revascularization rates than drug-coated balloons in non-focal in-stent restenosis

    Frontiers in Cardiovascular Medicine, 2026

    DOI 10.3389/fcvm.2026.1865693 PMID 42609246 Open-access full textSource: OpenAlex

  2. Sodium–glucose cotransporter-2 inhibitor use is associated with reduced acute kidney injury after transcatheter aortic valve implantation

    Frontiers in Cardiovascular Medicine, 2026

    DOI 10.3389/fcvm.2026.1799940 PMID 41969667 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  3. SGLT2 Inhibitor Therapy and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with Low Ejection Fraction

    Medicina, 2026

    DOI 10.3390/medicina62030535 PMID 41901616 4 citations (Europe PMC) Open-access full textSource: OpenAlex

  4. Combined umbilical cord-derived mesenchymal stem cell exosome and cell therapy in heart failure with reduced ejection fraction

    Regenerative Medicine, 2026

    DOI 10.1080/17460751.2026.2723032 PMID 42638332 1 citation (Europe PMC) Open-access full textSource: OpenAlex

  5. Prognostic value of pre- and post-procedural TAPSE/PASP ratio for long-term mortality in patients with left ventricular ejection fraction < 50% undergoing transcatheter aortic valve implantation

    Advances in Interventional Cardiology, 2026

    DOI 10.5114/aic.2026.164566 PMID 42965060 Open-access full textSource: OpenAlex

  6. Initial Clip Selection and Outcomes After Mitral Transcatheter Edge-to-Edge Repair: A Single-Center Experience

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15208176 PMID 42941689 Open-access full textSource: OpenAlex

  7. Reversible Right-to-Left Shunt After Mitral TEER Resolved by Tricuspid TEER

    JACC Case Reports, 2026

    DOI 10.1016/j.jaccas.2026.109734 PMID 42569989 Open-access full textSource: OpenAlex